We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+63.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$94.4M
AUM Growth
-$26.5M
Cap. Flow
-$21.4M
Cap. Flow %
-22.69%
Top 10 Hldgs %
48.28%
Holding
43
New
2
Increased
2
Reduced
28
Closed
4

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.72M
2
GG
Goldcorp Inc
GG
+$2.29M
3
CVS icon
CVS Health
CVS
+$740K
4
INTC icon
Intel
INTC
+$200K

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.36M
2
C icon
Citigroup
C
+$1.8M
3
MSFT icon
Microsoft
MSFT
+$1.78M
4
QCOM icon
Qualcomm
QCOM
+$1.62M
5
AAPL icon
Apple
AAPL
+$1.61M

Sector Composition

Rank Sector Weight
1 Technology 20.7%
2 Healthcare 19.74%
3 Materials 13.33%
4 Financials 11.86%
5 Communication Services 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.25T
$5.23M 5.54%
100,880
-42,580
-30% -$2.36M
MOS icon
2
The Mosaic Company
MOS
$7.19B
$4.88M 5.17%
201,000
-21,550
-10% -$567K
AAPL icon
3
Apple
AAPL
$4.8T
$4.87M 5.15%
116,000
-37,400
-24% -$1.61M
C icon
4
Citigroup
C
$224B
$4.86M 5.15%
72,020
-23,995
-25% -$1.8M
MSFT icon
5
Microsoft
MSFT
$2.92T
$4.83M 5.12%
52,950
-19,450
-27% -$1.78M
CVS icon
6
CVS Health
CVS
$141B
$4.66M 4.93%
74,910
+10,310
+16% +$740K
SLB icon
7
SLB Ltd
SLB
$70.8B
$4.12M 4.36%
63,545
-19,215
-23% -$1.34M
AGN
8
DELISTED
Allergan plc
AGN
$4.09M 4.33%
24,290
+22,190
+1,057% +$3.72M
DD icon
9
DuPont de Nemours
DD
$19B
$4.06M 4.3%
25,164
-6,219
-20% -$1.12M
CMCSA icon
10
Comcast
CMCSA
$85.9B
$4M 4.23%
116,925
-30,800
-21% -$1.19M
QCOM icon
11
Qualcomm
QCOM
$185B
$3.76M 3.98%
67,800
-25,500
-27% -$1.62M
HES
12
DELISTED
Hess
HES
$3.63M 3.84%
71,703
-3,350
-4% -$164K
IP icon
13
International Paper
IP
$19.8B
$3.42M 3.62%
67,579
-28,184
-29% -$1.57M
PFE icon
14
Pfizer
PFE
$143B
$3.39M 3.59%
100,683
-20,313
-17% -$698K
DAL icon
15
Delta Air Lines
DAL
$55.2B
$3.15M 3.34%
57,500
-14,000
-20% -$772K
UAL icon
16
United Airlines
UAL
$38.1B
$3.11M 3.29%
44,785
-7,100
-14% -$491K
CSCO icon
17
Cisco
CSCO
$446B
$2.99M 3.17%
69,700
-23,900
-26% -$1.01M
EMR icon
18
Emerson Electric
EMR
$78.7B
$2.68M 2.84%
39,220
-10,935
-22% -$779K
MDT icon
19
Medtronic
MDT
$105B
$2.46M 2.61%
30,700
-6,770
-18% -$558K
GG
20
DELISTED
Goldcorp Inc
GG
$2.35M 2.48%
+169,660
New +$2.29M
AIG icon
21
American International
AIG
$42B
$2.24M 2.37%
41,155
-18,760
-31% -$1.11M
GILD icon
22
Gilead Sciences
GILD
$163B
$2.23M 2.36%
29,550
-5,680
-16% -$452K
CCI icon
23
Crown Castle
CCI
$33.4B
$2.13M 2.26%
19,460
-10,510
-35% -$1.14M
MTSI icon
24
MACOM Technology Solutions
MTSI
$21.3B
$2.06M 2.18%
124,275
-3,375
-3% -$87K
USB icon
25
US Bancorp
USB
$99.6B
$1.34M 1.41%
26,450
-6,250
-19% -$342K

Similar funds

Colrain Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Colrain Capital held 43 positions worth $94.4M, down 22% from $121M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Colrain Capital withdrew a net $21.4M in Q1 2018, closing 4 positions and reducing 28 holdings. Its most notable exit was Kroger, an estimated $852K position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Colrain Capital opened a new position in Goldcorp Inc worth $2.35M.

  • Colrain Capital's largest Q1 2018 buy was Goldcorp Inc: 169,660 shares worth $2.35M.
  • Colrain Capital added most to Allergan plc in Q1 2018, an estimated $3.72M increase.
  • Colrain Capital's biggest Q1 2018 reduction was Alphabet (Google) Class A, cutting an estimated $2.36M.
  • Colrain Capital fully exited Kroger in Q1 2018, selling an estimated $852K.
  • Colrain Capital's ten largest holdings make up 48% of its $94.4M portfolio in Q1 2018.
  • Colrain Capital opened 2 new positions and closed 4 in Q1 2018.
  • Colrain Capital's portfolio value fell 22% quarter-over-quarter to $94.4M.

Based on Colrain Capital's 13F filing for Q1 2018, filed 14 May 2018.